These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20355163)

  • 1. Anti-doping testing at the 2008 European football championship.
    Vouillamoz M; Thom C; Grisdale R; Saugy M; Giraud S; Robinson N; Gmeiner G; Geisendorfer T
    Drug Test Anal; 2009 Nov; 1(11-12):485-93. PubMed ID: 20355163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidoping programme and biological monitoring before and during the 2014 FIFA World Cup Brazil.
    Baume N; Jan N; Emery C; Mandanis B; Schweizer C; Giraud S; Leuenberger N; Marclay F; Nicoli R; Perrenoud L; Robinson N; Dvorak J; Saugy M
    Br J Sports Med; 2015 May; 49(9):614-22. PubMed ID: 25878079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues of testing for hGH: collection.
    Uryasz F
    Drug Test Anal; 2009 Sep; 1(9-10):437-8. PubMed ID: 20355227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doping control container for urine stabilization: a pilot study.
    Tsivou M; Giannadaki E; Hooghe F; Roels K; Van Gansbeke W; Garribba F; Lyris E; Deventer K; Mazzarino M; Donati F; Georgakopoulos DG; Van Eenoo P; Georgakopoulos CG; de la Torre X; Botrè F
    Drug Test Anal; 2017 May; 9(5):699-712. PubMed ID: 27497113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of manipulation in doping control urine sample collection: a multidisciplinary approach to determine identical urine samples.
    Thevis M; Geyer H; Mareck U; Sigmund G; Henke J; Henke L; Schänzer W
    Anal Bioanal Chem; 2007 Aug; 388(7):1539-43. PubMed ID: 17260133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives and strategies for anti-doping analysis.
    Protti M; Mandrioli R; Mercolini L
    Bioanalysis; 2019 Feb; 11(3):149-152. PubMed ID: 30663332
    [No Abstract]   [Full Text] [Related]  

  • 7. Stabilization of human urine doping control samples: a current opinion.
    Tsivou M; Georgakopoulos DG; Dimopoulou HA; Koupparis MA; Atta-Politou J; Georgakopoulos CG
    Anal Bioanal Chem; 2011 Aug; 401(2):553-61. PubMed ID: 21499681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of longitudinal steroid profiles from male football players in UEFA competitions between 2008 and 2013.
    Baume N; Geyer H; Vouillamoz M; Grisdale R; Earl M; Aguilera R; Cowan DA; Ericsson M; Gmeiner G; Kwiatkowska D; Kioukia-Fougia N; Molina A; Ruivo J; Segura J; Van Eenoo P; Jan N; Robinson N; Saugy M
    Drug Test Anal; 2016 Jul; 8(7):603-12. PubMed ID: 26338140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The uefa euro 2012 anti-doping programme - scientific review.
    Earl M; Vouillamoz M; Kwiatkowska D; Turek-Lepa E; Pokrywka A; Saugy M; Baume N; Gmeiner G
    Biol Sport; 2014 Jun; 31(2):85-93. PubMed ID: 24899771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and perspectives in anti-doping testing.
    Schamasch P; Rabin O
    Bioanalysis; 2012 Jul; 4(13):1691-701. PubMed ID: 22831484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
    Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
    Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and old challenges of sports drug testing.
    Botrè F
    J Mass Spectrom; 2008 Jul; 43(7):903-7. PubMed ID: 18570180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence flow cytometer to determine urine particle reference intervals in doping control samples.
    Robinson N; Sottas PE; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):95-100. PubMed ID: 21889276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical challenges in the detection of peptide hormones for anti-doping purposes.
    Barroso O; Handelsman DJ; Strasburger C; Thevis M
    Bioanalysis; 2012 Jul; 4(13):1577-90. PubMed ID: 22831474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved gas chromatography screening method for doping substances using triple quadrupole mass spectrometry, with an emphasis on quality assurance.
    De Brabanter N; Van Gansbeke W; Geldof L; Van Eenoo P
    Biomed Chromatogr; 2012 Nov; 26(11):1416-35. PubMed ID: 22362568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma volume expanders: use in medicine and detecting misuse in sports.
    Simoni RE; Scalco FB; de Oliveira ML; Aquino Neto FR
    Bioanalysis; 2011 Jan; 3(2):215-26. PubMed ID: 21250849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do dried blood spots (DBS) have the potential to support result management processes in routine sports drug testing?
    Thevis M; Kuuranne T; Dib J; Thomas A; Geyer H
    Drug Test Anal; 2020 Jun; 12(6):704-710. PubMed ID: 32180361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.